Merck Q1 Non-GAAP EPS of $2.14beats by $0.31.Revenue of $15.9B (+49.6% Y/Y)beats by $1.26B.LAGEVRIO Sales Were $3.2 Billion, Growth Excluding LAGEVRIO Was 19%; Sales Growth Favorably Impacted by COVID...
Source LinkMerck Q1 Non-GAAP EPS of $2.14beats by $0.31.Revenue of $15.9B (+49.6% Y/Y)beats by $1.26B.LAGEVRIO Sales Were $3.2 Billion, Growth Excluding LAGEVRIO Was 19%; Sales Growth Favorably Impacted by COVID...
Source Link
Comments